UC San Diego Health Leads the Way in Medical Technology with Dual Chamber and Leadless Pacemaker System Implantation

UC San Diego Health Becomes First in Region to Perform Dual-Chamber, Leadless Pacemaker Implantation

UC San Diego Health has achieved a significant milestone in the world of medical technology by implanting the first dual chamber and leadless pacemaker system in San Diego. This innovative system aims to help individuals with irregular heart rhythms, known as arrhythmias, that can lead to complications like palpitations, fainting, and stroke.

Atrial fibrillation is the most common type of arrhythmia, estimated to affect around 12.1 million people in the United States by 2030 according to the Centers for Disease Control and Prevention. Pacemakers and implantable cardioverter defibrillators (ICDs) are the standard treatments used to regulate irregular heartbeats. However, this new leadless pacemaker system offers a more minimally invasive option for patients by being placed in both chambers of the heart and utilizing novel communication technology.

Approved by the U.S. Food and Drug Administration (FDA) in July 2023, this advancement in technology opens up new possibilities for treating individuals with heart arrhythmias. Dr. Ulrika Birgersdotter-Green, a cardiologist and the director of pacemaker and ICD services at UC San Diego Health, highlighted the importance of having the option to use a leadless pacemaker system on both sides of the heart to treat more individuals living with heart arrhythmias.

It is essential to note that nearly 80% of patients who receive a pacemaker require a dual chamber option. While leadless pacemakers have been preferred by patients due to their minimally invasive nature, they were typically only available for individuals needing pacing on one side of the heart. This recent development represents a significant step forward in the treatment of arrhythmias and offers new hope for patients in need of such interventions.

UC San Diego Health conducted the first implantation of the pacemaker system in a patient in February 2024, highlighting their commitment to providing innovative solutions for their patients’ health needs.

In conclusion, this new leadless pacemaker system represents an exciting advancement in medical technology that offers hope for individuals with irregular heart rhythms like atrial fibrillation. With its ability to be placed in both chambers of the heart and utilize novel communication technology, it provides a more minimally invasive treatment option that is crucial for many patients who require dual chamber options.

Overall, this achievement by UC San Diego Health marks an important milestone in improving patient outcomes for those suffering from arrhythmias through advanced medical technologies like leadless pacemaker systems.

Leave a Reply